Insulet Corporation - Common Stock (NQ:PODD)

Discover Insulet (PODD), a top growth stock with strong financials and a positive technical setup, making it a compelling pick for investors.

INSULET CORP (NASDAQ:PODD) Demonstrates Strong Growth and Technical Momentum

October 29, 2025

Via Chartmill

Price Over Earnings Overview: Insulet

September 30, 2025

Via Benzinga

1 Safe-and-Steady Stock to Own for Decades and 2 We Brush Off

October 27, 2025

Stability is great, but low-volatility stocks may struggle to deliver market-beating returns over time as they sometimes underperform during bull markets.

Insulet (PODD) is a GARP stock with strong revenue & earnings growth, solid profitability, and a reasonable valuation relative to its industry peers.

INSULET CORP (NASDAQ:PODD): A Prime Candidate for Affordable Growth Investing

October 25, 2025

Via Chartmill

Insulet Announces Appointment of Robert L. Huffines to its Board of Directors

October 23, 2025

Discover how Louis Navellier's growth stock strategy identified Insulet Corp (PODD), a leader in innovative insulin delivery with strong earnings and sales growth.

Here's How Much You Would Have Made Owning Insulet Stock In The Last 10 Years

October 21, 2025

Via Benzinga

Louis Navellier's Growth Strategy Highlights Insulet Corp (NASDAQ:PODD)

October 20, 2025

Via Chartmill

Insulet to Host Investor Day on November 20, 2025

October 10, 2025

Wondering what's happening in today's session for the S&P500 index? Stay informed with the top movers within the S&P500 index on Thursday.

Discover which S&P500 stocks are making waves on Thursday.

October 09, 2025

Via Chartmill

What's going on in today's session: S&P500 gap up and gap down stocks

October 01, 2025

Let's have a look at the S&P500 gap up and gap down stocks in today's session.

Via Chartmill

Here's How Much $100 Invested In Insulet 15 Years Ago Would Be Worth Today

September 29, 2025

Insulet (NASDAQ: PODD) has outperformed the market over the past 15 years by 10.02% on an annualized basis producing an average annual return of 22.35%. Currently, Insulet has a market capitalization...

Via Benzinga

A Glimpse Into The Expert Outlook On Insulet Through 6 Analysts

September 29, 2025

6 analysts have shared their evaluations of Insulet (NASDAQ: PODD) during the recent three months, expressing a mix of bullish and bearish perspectives.

Via Benzinga

Insulet Corp (NASDAQ:PODD): An Affordable Growth Stock with Strong Profitability

September 27, 2025

Insulet Corp (PODD) exemplifies affordable growth with strong revenue & EPS expansion, high profitability, and a valuation justified by its industry-leading potential.

Via Chartmill

Align Technology, ResMed, Insulet, Envista, and Dentsply Sirona Shares Plummet, What You Need To Know

September 25, 2025

A number of stocks fell in the afternoon session after the U.S. Commerce Department initiated a national security investigation into medical equipment and devices, raising concerns about potential...

Topics World Trade

Here's How Much $100 Invested In Insulet 10 Years Ago Would Be Worth Today

September 19, 2025

Via Benzinga

Insulet and Pantone® Partner to Launch Omnipod® Mango in Vibrant New Palette

September 18, 2025

Shares of insulin delivery company Insulet Corporation (NASDAQ:PODD) fell 4.3% in the morning session after the company announced a change in its chief financial officer, a move that appeared to...

Why Insulet (PODD) Shares Are Falling Today

September 17, 2025

Tech Stocks Slip, Small Caps Soar Ahead Of Fed Rate Decision: What's Moving Markets Wednesday?

Topics Economy

September 17, 2025

Small-cap and blue-chip stocks advanced in Wednesday morning trading on Wall Street, while technology names lagged and the S&P 500 hovered near record levels as investors braced for the Federal...

Via Benzinga

Topics Economy

Top S&P500 movers in Wednesday's session

September 17, 2025

Curious about the S&P500 stocks that are in motion on Wednesday? Join us as we explore the top movers within the S&P500 index during today's session.

Via Chartmill

Gapping S&P500 stocks in Wednesday's session

September 17, 2025

Let's have a look at the S&P500 gap up and gap down stocks in today's session.

Via Chartmill

Insulet Announces CFO Transition

September 16, 2025

Insulet has had an impressive run over the past six months as its shares have beaten the S&P 500 by 18%. The stock now trades at $337, marking a 35.7% gain. This was partly thanks to its solid...

3 Reasons Investors Love Insulet (PODD)

September 12, 2025

ResMed, Insulet, Lantheus, Inspire Medical Systems, and Evolent Health Shares Plummet, What You Need To Know

Topics Stocks

September 10, 2025

A number of stocks fell in the afternoon session after markets pulled back, reversing early gains, as investor sentiment remained cautious despite a softer-than-expected inflation reading.

Uncover the latest developments among S&P500 stocks in today's session. Stay tuned to the S&P500 index's top gainers and losers on Wednesday.

Topics Economy

Which S&P500 stocks are moving on Wednesday?

September 10, 2025

Via Chartmill

These S&P500 stocks are gapping in today's session

September 10, 2025

Let's take a look at the S&P500 stocks that are experiencing notable price gaps in today's session on Wednesday. Discover the gap up and gap down stocks in the S&P500 index.

Via Chartmill

Insulet Corp (NASDAQ:PODD) Combines Technical Strength and Fundamental Momentum for High-Growth Potential

September 10, 2025

Insulet Corp (PODD) combines strong technical uptrends with accelerating earnings and revenue growth, making it a top high-growth momentum stock.

Via Chartmill

3 S&P 500 Stocks to Target This Week

September 09, 2025

The S&P 500 (^GSPC) is packed with companies that have built dominant market positions, making it a core index for investors. A select few continue to innovate and expand, setting themselves up for...